Orion Pharma is engaged in the research, development, manufacture and marketing of pharmaceuticals and drug substances, as well as drug-related products for the prevention and treatment of diseases. The product portfolio encompasses all elementary therapy groups, also veterinary drugs.
International operations account for approximately half of the net sales.
The growth of the business is increasingly based on drugs resulting from the company's own pharmaceutical research activity. Orion has several drug manufacturing plants in Finland, and one in Denmark. For marketing pharmaceuticals, Orion has own subsidiaries and sales representative networks in Sweden, Norway, Denmark, Germany, France, the UK and Ireland, Switzerland and Hungary. Orion Pharma has also marketing agreements with Novartis, Abbott Laboratories and Nippon Kayaku.